Work

A randomized, double‐blind, placebo‐controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neurogastroenterology & Motility

DOI: 10.1111/nmo.14523

Authors: Thomas L. Abell, Braden Kuo, Tuba Esfandyari, Nathan D. Pfeifer, Maria Grimaldi, Cecilia Renzulli, Raffaella Tacchi, Kefei Zhou, Chris N. Barnes, Deanna D. Nguyen, Linda Nguyen, Nicholas J. Talley, Richard McCallum

Institutions: University of Louisville, Massachusetts General Hospital, University of Kansas, University of Kansas Medical Center, Theravance Biopharma (United States), Alfasigma (Italy), Stanford Medicine, Stanford University, University of Newcastle Australia, Texas Tech University

Language: English

Topic: Gastrointestinal motility and disorders

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4315437039

FWCI: 5.389

Cites: 34

Cited by: 19

Related to: 10